Biosimilars in Oncology: Latest Trends and Regulatory Status

Biologic-based medicines are used to treat a variety of diseases and account for around one-quarter of the worldwide pharmaceutical market. The use of biologic medications among cancer patients has resulted in substantial advancements in cancer treatment and supportive care. Biosimilar medications (...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Deeksha, Khursheed, Rubiya, Gupta, Saurabh, Wadhwa, Diksha, Singh, Thakur Gurjeet, Sharma, Sumit, Porwal, Sejal, Gauniyal, Swati, Vishwas, Sukriti, Goyal, Sanjay, Gupta, Gaurav, Eri, Rajaraman D., Williams, Kylie A., Dua, Kamal, Singh, Sachin Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784530/
https://www.ncbi.nlm.nih.gov/pubmed/36559215
http://dx.doi.org/10.3390/pharmaceutics14122721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784530/
https://www.ncbi.nlm.nih.gov/pubmed/36559215
http://dx.doi.org/10.3390/pharmaceutics14122721

Ejemplares similares